FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089006 [Registered on: 17/06/2025] Trial Registered Prospectively
Last Modified On: 17/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of hyperbaric solutions of bupivacaine, levobupivacaine and ropivacaine in spinal anaesthesia for elective surgery: a prospective randomised double-blind study  
Scientific Title of Study   Comparison of hyperbaric solutions of Bupivacaine, Levobupivacaine and Ropivacaine in Spinal anaesthesia for elective surgery: A prospective, Randomised, double-blind study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Aishani Chawla 
Designation  Junior Resident  
Affiliation  H.B.T.M.C and Dr R.N. Cooper hospital, Mumbai  
Address  Department of Anaesthesiology, H.B.T.M.C and Dr R.N Cooper hospital, Ville Parle west, Mumbai

Mumbai
MAHARASHTRA
400056
India 
Phone  7795362668  
Fax    
Email  aishanichawla@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Naina Dalvi 
Designation  Additional Professor 
Affiliation  H.B.T.M.C and Dr R.N. Cooper hospital, Mumbai  
Address  Department of Anaesthesiology, H.B.T.M.C and Dr R.N Cooper hospital, Ville Parle west, Mumbai

Mumbai
MAHARASHTRA
400056
India 
Phone  7795362668  
Fax    
Email  drnaina@rediffmail.com  
 
Details of Contact Person
Public Query
 
Name  Aishani Chawla 
Designation  Junior Resident  
Affiliation  H.B.T.M.C and Dr R.N. Cooper hospital, Mumbai  
Address  Department of Anaesthesiology, H.B.T.M.C and Dr R.N Cooper hospital, Ville Parle west, Mumbai

Mumbai
MAHARASHTRA
400056
India 
Phone  7795362668  
Fax    
Email  aishanichawla@gmail.com  
 
Source of Monetary or Material Support  
Aishani Chawla  
Department of Anesthesiology , Hinduhrudaysamrat Balasaheb Thackeray Medical College and Dr R.N. Cooper hospital, Ville Parle west, Mumbai -400056 
 
Primary Sponsor  
Name  HBTMC and Dr RN Cooper hospital 
Address  Department of Anaesthesiology, H.B.T.M.C and Dr R.N Cooper hospital, Ville Parle west, Mumbai 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aishani Chawla  Dr R.N.Cooper hospital  Department of Anesthesiology, H.B.T.MC and Dr R.N.Cooper hospital, Ville Parle west, Mumbai 400056
Mumbai
MAHARASHTRA 
7795362668

aishanichawla@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 2  
Name of Committee  Approval Status 
Instituitional Ethics Comitee, H.B.T.M.C  Approved 
Instituitional Ethics Comitee, H.B.T.M.C  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K612||Anorectal abscess, (2) ICD-10 Condition: N819||Female genital prolapse, unspecified, (3) ICD-10 Condition: N979||Female infertility, unspecified, (4) ICD-10 Condition: N433||Hydrocele, unspecified, (5) ICD-10 Condition: O||Medical and Surgical, (6) ICD-10 Condition: O||Medical and Surgical, (7) ICD-10 Condition: O021||Missed abortion, (8) ICD-10 Condition: K36||Other appendicitis, (9) ICD-10 Condition: N849||Polyp of female genital tract, unspecified, (10) ICD-10 Condition: N434||Spermatocele of epididymis, (11) ICD-10 Condition: K409||Unilateral inguinal hernia, without obstruction or gangrene, (12) ICD-10 Condition: K469||Unspecified abdominal hernia without obstruction or gangrene,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Hyperbaric Bupivacaine  administeration of spinal anesthesia drug in consenting patients; 0.5% Hyperbaric Bupivacaine intrathecally; for duration of surgery 
Comparator Agent  Hyperbaric Levobupivacaine   administeration of spinal anesthesia drug in consenting patients; 0.5% Hyperbaric Levobupivacaine intrathecally; for duration of surgery 
Comparator Agent  Hyperbaric Ropivacaine   administeration of spinal anesthesia drug in consenting patients; 0.5% Hyperbaric Bupivacaine intrathecally; for duration of surgery 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA I and II 
 
ExclusionCriteria 
Details  ASA III and IV
Blood Dyscrasias
Clotting disorders
Pregnant and Lactating
History of hypersensitivity disorders
Pain modifying drugs


 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Onset and duration of sensory blockade with the three drugs




 
assessement done every minute till 5 minutes, every 5 minutes thereafter till end of procedure; post procedure assesment done evry 30 min till level recedes completely




 
 
Secondary Outcome  
Outcome  TimePoints 
1.Onset & duration of motor blockade
2. Effect on heart rate
3. Effect on MAP
4. Effect on PONV
 
1. assessement done every minute till 5 minutes, every 5 minutes thereafter till end of procedure; post procedure assesment done evry 30 min till level recedes completely
2. assessement done every minute till 5 minutes, every 5 minutes thereafter till end of procedure.
3. assessement done every minute till 5 minutes, every 5 minutes thereafter till end of procedure.
4. Intra operative & post operative till 24 hours  
 
Target Sample Size   Total Sample Size="75"
Sample Size from India="75" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   30/06/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  30/06/2025 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="2"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

We are comparing bupivacaine with ropivacaine and levobupivacaine with the aim of studying clinical efficacy of hyperbaric bupivacaine, levobupivacaine and ropivacaine with respect to sensory and motor block characteristics, haemodynamic parameters and adverse effects.

Seventy five patients satisfying the inclusion and exclusion criteria undergoing elective lower limb and lower abdominal surgeries will be  enrolled in our study after obtaining written informed consent.  Patients will be  randomly       allocated into 3 groups of 25 each, receiving 3 ml of 0.5% hyperbaric bupivacaine, levobupivacaine and ropivacaine.      

All data will be  compiled in a case record form. Data will be analysed using SPSS v21. Chi square test will be  used as test of significance for categorical data and ANOVA test will be used as test of significance for continuous data (comparison of three groups means). Post hoc comparative analysis will be  done to determine statistical significance among the three groups. P value less than 0.05 would considered as statistically significant.

 The demographic data such as age, sex, height, weight and ASA grades, operative procedures and duration of surgery would be collected.

Parameters noted in case record form will be :

  • Mean Time of onset of sensory block (T8) 
  •   Mean Time to reach peak sensory block 
  •  Maximal sensory level was assessed; 
  •  Time for 2 segment regressions of sensory level 
  • The mean Duration of sensory blockade (Tanes
  • The mean Onset time of motor blockade
  • The mean Duration of Motor Blockade 
  • Haemodynamic parameters like pulse rate, blood pressure, respiratory rate and saturation 
  •  Mean arterial pressure 
  • The mean Time taken to Walk without support 
  • The mean Time taken to Void  
  • Perioperative adverse events  

 
Close